Home-Based Tele-Rehabilitation for Respiratory Function in Children With Duchenne Muscular Dystrophy
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Home-Based Respiratory Telerehabilitation Program.
- Who it may be relevant to
- Registry conditions: Duchene Muscular Dystrophy. Basic parameters: from 3 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- South Korea
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Feasibility and Preliminary Clinical Effects of a Home-Based, Remotely Delivered Respiratory Rehabilitation Program for Children With Duchenne Muscular Dystrophy
Overview
This study evaluates the feasibility and preliminary clinical effects of a home-based tele-rehabilitation program aimed at improving respiratory function in children with Duchenne Muscular Dystrophy (DMD).
Detailed description
This is a prospective single-arm interventional study evaluating a 6-week home-based tele-rehabilitation program for respiratory function in children with Duchenne Muscular Dystrophy. The intervention includes weekly remote education sessions and home-based exercises, with assessments conducted before and after the intervention and a 2-week follow-up for adherence monitoring.
Interventions
- Behavioral Home-Based Respiratory Telerehabilitation Program
A 6-week caregiver-assisted home-based respiratory telerehabilitation program for children with Duchenne muscular dystrophy. The program includes weekly remote education sessions, respiratory muscle exercises, airway clearance training, relaxation positioning, and self-directed home exercises performed at least 5 times per week. Outcomes are assessed before and after the intervention and at 2-week follow-up.
Primary outcome measures
- Feasibility of the Home-Based Respiratory Tele-rehabilitation Program [Time frame: Baseline to immediately after the 6-week intervention]
- Acceptability of the Home-Based Respiratory Tele-rehabilitation Program [Time frame: Immediately after the 6-week intervention and at 2-week follow-up]
Secondary outcome measures (5)
- Inspiratory Muscle Strength [Time frame: Baseline and immediately after the 6-week intervention]
- Expiratory Muscle Strength [Time frame: Baseline and immediately after the 6-week intervention]
- Respiratory Muscle Function [Time frame: Baseline and immediately after the 6-week intervention]
- Physical Functional Performance [Time frame: Baseline and immediately after the 6-week intervention]
- Functional Exercise Capacity [Time frame: Baseline and immediately after the 6-week intervention]
Eligibility criteria
Inclusion criteria
- Children aged 3 years or older with genetically confirmed Duchenne muscular dystrophy
- Participants who are able to understand the study procedures and appropriately participate in the study
Exclusion criteria
- Requirement for daytime ventilator support or invasive mechanical ventilation via tracheostomy (nighttime non-invasive ventilation such as positive airway pressure ventilation is allowed)
- History of peripheral nerve injury
- History of major surgery within 12 weeks prior to enrollment or expected major surgery during the study period
- History of central nervous system disorders (e.g., cerebral infarction or spinal cord injury)
- Severe cognitive impairment or other conditions that may interfere with participation in the study procedures
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
South Korea · 1 center
- Samsung Medical Center — Seoul
Identifiers
NCT: NCT07629284 · 2025-12-123